EUVIMEDEUVIMED entdecken
Crossref

Red blood cell casts on kidney biopsy and progression of IgA nephropathy

Yu-Xuan Yao iD, Chen Tang iD, Su-Fang Shi, Pei Chen, Xu-Jie Zhou, Ji-Cheng Lv, Li-Jun Liu, Hong Zhang

Nephrology Dialysis Transplantation · 2025

DOI: 10.1093/ndt/gfaf023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, 2025. Verfasst von Yu-Xuan Yao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Renal Division, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China. Hauptthemen laut MEDLINE: Glomerulonephritis, IGA, Erythrocytes, Kidney, Kidney Failure, Chronic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National High Level Hospital Clinical Research Funding, Peking University First Hospital, CAMS Innovation Fund for Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Renal red blood cell casts (RBCC) are common in IgA nephropathy (IgAN), but their role in kidney disease progression of patients with IgAN remains unclear.

Methods

In total, 1425 patients in a Peking University First Hospital IgAN (PKU-IgAN) cohort and 279 patients in the TESTING trial were enrolled to test the association between RBCC and kidney outcome. RBCC was defined as positive (+) when at least one cast was identified within the renal tubules by light microscopy. Kidney endpoint was the composite of the first occurrence of a sustained 30% decrease in estimated glomerular filtration rate or end stage kidney disease or death due to kidney disease. Cox regression analysis was used.

Results

In PKU-IgAN, 529 patients (37%) had RBCC; in the TESTING trial, 78 patients (28%) had RBCC. Patients with RBCC had more crescentic lesions, and less segmental sclerosis compared with patients without RBCC. In PKU-IgAN, after a median follow-up of 54 months, 119 patients (22%) with RBCC and 260 patients (29%) without RBCC reached the composite kidney endpoint (P = .009). In multivariable analysis, RBCC was independently associated with composite kidney endpoint [hazard ratios (HR) 0.79; 95% confidence interval (CI) 0.63–0.99; P = .038]. RBCC and immunosuppressive therapy (IST) had an interaction (P = .001). RBCC was independently associated with composite kidney endpoint in patients who received IST (HR 0.56; 95%CI 0.40–0.77; P < .001). In the TESTING trial, after a median follow-up of 57 months, 26 patients (33%) with RBCC, and 96 patients (48%) without RBCC reached the composite kidney endpoint (P = .041). In univariate analysis, RBCC was associated with composite kidney endpoint (HR 0.64; 95%CI 0.42–0.99; P = .047).

Conclusion

Renal RBCC was frequent in IgAN and was associated with a higher incidence of acute active lesions and better renal prognosis, especially in those who received IST, warranting particular attention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glomerulonephritis, IGAErythrocytesKidneyKidney Failure, ChronicHumansMaleFemaleDisease ProgressionAdultPrognosisFollow-Up StudiesBiopsyGlomerular Filtration RateMiddle AgedYoung AdultRisk Factors

Stichwörter der Autor:innen

IgA nephropathyhematuriaimmunosuppressive therapykidney progressionred blood cell casts

Autor:innen und Institutionen

  • Renal Division, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China.
  • Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China.
  • Research Units of Diagnosis and Treatment of Immune-Mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China.

ORCID-Profile: Yu-Xuan Yao, Chen Tang

Förderung

  • National High Level Hospital Clinical Research Funding
  • Peking University First Hospital
  • CAMS Innovation Fund for Medical Sciences
  • National Natural Science Foundation of China
  • National Science Fund for Young Scholars

Zitieren

APA

Yao, Y. X., Tang, C., Shi, S. F., Chen, P., Zhou, X. J., Lv, J. C., Liu, L. J., & Zhang, H. (2025). Red blood cell casts on kidney biopsy and progression of IgA nephropathy. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfaf023

Vancouver

Yao YX, Tang C, Shi SF, Chen P, Zhou XJ, Lv JC, et al. Red blood cell casts on kidney biopsy and progression of IgA nephropathy. Nephrology Dialysis Transplantation. 2025. doi:10.1093/ndt/gfaf023

BibTeX
@article{Yao2025,
  author = {Yao, Yu-Xuan and Tang, Chen and Shi, Su-Fang and Chen, Pei and Zhou, Xu-Jie and Lv, Ji-Cheng and Liu, Li-Jun and Zhang, Hong},
  title = {Red blood cell casts on kidney biopsy and progression of IgA nephropathy},
  journal = {Nephrology Dialysis Transplantation},
  year = {2025},
  doi = {10.1093/ndt/gfaf023}
}
Kostenlos starten →